Outcome in 43 children presenting with metastatic Ewing sarcoma: The St. Jude Children's Research Hospital experience, 1962 to 1992

Medical and Pediatric Oncology

Volumn 26, Issue 3, 1996, Pages 180-185

  Sandoval, Claudio ^a,c   Meyer, William H ^a,b   Parham, David M ^a   Kun, Larry E ^a,b   Hustu, H Omar ^a   Luo, Xiaolong ^a   Pratt, Charles B ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

chemotherapy; Ewing sarcoma; metastases; radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERLEUKIN 2; MESNA; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; EWING SARCOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0030045055     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199603)26:3<180::AID-MPO6>3.0.CO;2-G     Document Type: Article

References (27)

1. Ewing J: Diffuse endothelioma of bone. Proc NY Pathol Soc 21:17-24, 1921.
2. Dehner LP: Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 17:1-13, 1993.
3. Cavazzana AO, Miser JD, Jefferson J, Triche TJ: Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 127.507-518, 1987.
4. Jurgens H, Exner U, Gadner H, Harms D, Michaelis J, Sauer R, et al: Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 61:23-32, 1988.
5. Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Forquer R, Wesley R, et al: Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: Six months of intensive combined modality therapy without maintenance. J Clin Oncol 6:484-490, 1988.
6. Bacci G, Toni A, Avella M, Manfrini M, Sundanese A, Ciaroni D, et al: Long term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 63:1477-1486, 1989
7. Hayes FA, Thompson EI, Meyer WH, Kun L, Parham D, Rao B, et al: Therapy for localized Eqing's sarcoma of bone. J Clin Oncol 7:208-213, 1989.
8. Burgert EO, Nesbit ME, Garnsey LA, Gehan EA, Herrmann J, Vietti TJ, et al: Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma on bone: Intergroup Study IESS-II. J Clin Oncol 8:1514-1524, 1990.
9. Nesbit ME, Gehan EA, Burgert EO, Vietti TJ. Cangir A. Tefft M. et al: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the First Intergroup Study. J Clin Oncol 8:1664-1674, 1990.
10. Barbieri E, Emiliana E, Zini G, Mancini A, Toni A, Frezza G, et al: Combined therapy of localized Ewing's sarcoma of bone: Analysis of results in 100 patients. Int J Radiat Oncol Biol Phys 19:1165-1170, 1990.
11. Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert O, Vietti TJ, et al: Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: A report from the Second Intergroup Study. J Clin Oncol 9:1173-1180, 1991.
12. Bacci G, Ferrari S, Avella M, Barbieri E, Picci P, Casadie R, et al: Non-metastatic Ewing's sarcoma: Results in 98 patients treated with neoadjuvant chemotherapy. Ital J Orthop Traumatol 17:449-465, 1991
13. Oberlin O, Habrand JL, Zucker JM, Brunat-Mentigny M, Terrier-Lacombe M-J. Dobousset J, et al: No benefit of ifosfamide in Ewing's sarcoma: A nonrandomized study of the French Society of Pediatric Oncology. J Clin Oncol 10:1407-1412, 1992.
14. Hayes FA, Thompson EI, Parvey L, Rao B, Kun L, Parham D, et al: Metastatic Ewing's sarcoma: Remission induction and survival. J Clin Oncol 5:1199-1204, 1987.
15. Lanza LA, Miser JA, Pass HI, Roth JA: The role of resection in the treatment of pulmonary metastases from Ewing's sarcoma. J Thorac Cardiovasc Surg 94:181-187, 1987.
16. Wessalowski R, Jurgens H, Bodenstein II, Brandeis W, Gutjahr P, Havers W, et al: Results of treatment of primary metastatic Ewing's sarcoma. A retrospective analysis of 48 patients. Klin Padiatr 200:253-260, 1989.
17. Cangir A, Vietti TJ, Gehan EA, Burgert EO, Thomas P, Tefft M, et al: Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two Intergroup Ewing's sarcoma studies. Cancer 66: 887-892, 1990.
18. Hayes FA, Thompson EI, Hustu HO, Kumar M, Cobum T, Webber B: The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy. J Clin Oncol 1:45-51, 1983.
19. Meyer WH, Kun L, Marina N, Roberson P, Parham D, Rao B, et al: Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol 10:1737-1742, 1992.
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
21. Kalbfleisch JD, Prentice RL: "The Statistical Analysis of Failure Time Data." New York: John Wiley and Sons, 1980.
22. Peto R, Pike MC, Armitage P, Breslow N, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part 2. Analysis and examples. Br J Cancer 35:1-39, 1977.
23. Smith MA, Ungerleider RS, Horowitz MR, Simon R: Influence of doxorubicin fose intensity on response and outcome for patient with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst 83:1469-1470, 1991.
24. Marcus RB, Graham-Pole JR, Springfield DS, Fort JS, Gross S, Mendenhall NP, et al: High-risk Ewing's sarcoma: End-intensification using autologous bone marrow transplantation. Int J Radiat Oncol Biol Phys 15:53-59, 1988.
25. Burdach S. Jurgens H, vanValen F, Zessak N, Dilloo D, Hanenberg H, et al: Myeloablation, stem cell grafting, and cytokine therapy in poor prognosis Ewing sarcoma: Current concepts and future directions. Bone Marrow Transplantation 10(Suppl 2):18, 1992.
26. Burdach S, Jurgens H, Peters C, Nurnberger W, Mauz-Korholz C, Korholz D, et al: Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 11:1482-1488, 1993.
27. Horowitz ME, Kinsella TJ, Wexler LH, Belasco J, Triche T, Tsokos M, et al: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911-1918, 1993.